Pathogenesis of liver fibrosis.

Liver fibrosis is a major cause of morbidity and mortality worldwide due to chronic viral hepatitis and, more recently, from fatty liver disease associated with obesity. Hepatic stellate cell activation represents a critical event in fibrosis because these cells become the primary source of extracellular matrix in liver upon injury. Use of cell-culture and animal models has expanded our understanding of the mechanisms underlying stellate cell activation and has shed new light on genetic regulation, the contribution of immune signaling, and the potential reversibility of the disease. As pathways of fibrogenesis are increasingly clarified, the key challenge will be translating new advances into the development of antifibrotic therapies for patients with chronic liver disease.

[1]  Scott L. Friedman,et al.  Evolving challenges in hepatic fibrosis , 2010, Nature Reviews Gastroenterology &Hepatology.

[2]  V. Reichenbach,et al.  [Endogenous cannabinoids in liver disease: Many darts for a single target]. , 2010, Gastroenterologia y hepatologia.

[3]  K. Iwaisako,et al.  Hepatocytes do not undergo epithelial‐mesenchymal transition in liver fibrosis in mice , 2010, Hepatology.

[4]  R. Wells The epithelial‐to‐mesenchymal transition in liver fibrosis: Here today, gone tomorrow? , 2010, Hepatology.

[5]  D. Mann,et al.  NF-kappaB signalling: embracing complexity to achieve translation. , 2010, Journal of hepatology.

[6]  W. Jiménez,et al.  [Endogenous cannabinoids in liver disease: Many darts for a single target]. , 2010, Gastroenterologia y hepatologia.

[7]  Natalie J Torok,et al.  Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[8]  G. Szabo,et al.  Emerging role of microRNAs in liver diseases. , 2009, World journal of gastroenterology.

[9]  P. Angus,et al.  Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. , 2009, Clinical science.

[10]  A. Diehl,et al.  Epithelial‐to‐mesenchymal transitions in the liver , 2009, Hepatology.

[11]  D. Bar-Sagi,et al.  In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. , 2009, The Journal of clinical investigation.

[12]  Yoshinobu Sato,et al.  Clinicopathological analysis of CD133+ and NCAM+ human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  E. Novo,et al.  Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis. , 2009, The international journal of biochemistry & cell biology.

[14]  J. Sicklick,et al.  Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[15]  J. Iredale,et al.  Reversibility of liver fibrosis. , 2009, Annals of hepatology.

[16]  Y. Inagaki,et al.  Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. , 2009, Gastroenterology.

[17]  D. Schuppan,et al.  Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies , 2009, Hepatology.

[18]  F. Marra,et al.  Adipokines in liver diseases , 2009, Hepatology.

[19]  D. Brenner,et al.  Angiotensin‐converting‐enzyme 2 inhibits liver fibrosis in mice , 2009, Hepatology.

[20]  T. Cheng,et al.  Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways , 2009, The FEBS journal.

[21]  B. Gao,et al.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases , 2009, Journal of leukocyte biology.

[22]  M. Fujimiya,et al.  Pathological roles of bone marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[23]  V. Serre-Beinier,et al.  Fibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver , 2009, PloS one.

[24]  J. Mann,et al.  Transcriptional regulation of hepatic stellate cells. , 2009, Advanced drug delivery reviews.

[25]  D. Rockey,et al.  Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[26]  R. Schwabe,et al.  CCR1 and CCR5 promote hepatic fibrosis in mice. , 2009, The Journal of clinical investigation.

[27]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[28]  R. Bataller,et al.  Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. , 2009, Gastroenterology.

[29]  W. Jeong,et al.  Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride , 2009, Hepatology.

[30]  Olivia T. Abar,et al.  Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses , 2009, Hepatology.

[31]  Jaume Bosch,et al.  Angiogenesis in liver disease. , 2009, Journal of hepatology.

[32]  J. Fallowfield,et al.  Senescence of activated stellate cells: Not just early retirement , 2009, Hepatology.

[33]  J. Dranoff,et al.  Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. , 2009, Cell calcium.

[34]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[35]  E. Sontheimer,et al.  Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.

[36]  Guangcun Huang,et al.  Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation , 2009, FEBS letters.

[37]  D. Brenner,et al.  NK and NKT cells in liver injury and fibrosis. , 2009, Clinical immunology.

[38]  C. Hellerbrand,et al.  Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. , 2008, Biochemical and biophysical research communications.

[39]  R. Bataller,et al.  Cytokines and renin-angiotensin system signaling in hepatic fibrosis. , 2008, Clinics in liver disease.

[40]  A. Burt,et al.  Fibrosis and cirrhosis reversibility - molecular mechanisms. , 2008, Clinics in liver disease.

[41]  D. Schuppan,et al.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. , 2008, The Journal of clinical investigation.

[42]  S. Pol,et al.  Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C , 2008, Annals of Internal Medicine.

[43]  R. Kalluri,et al.  The role of endothelial-to-mesenchymal transition in cancer progression , 2008, British Journal of Cancer.

[44]  S. Friedman,et al.  Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis , 2008, Hepatology.

[45]  S. Lowe,et al.  Senescence of Activated Stellate Cells Limits Liver Fibrosis , 2008, Cell.

[46]  S. Glaser,et al.  Leptin enhances cholangiocarcinoma cell growth. , 2008, Cancer research.

[47]  B. Garmy-Susini,et al.  Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.

[48]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[49]  Y. Inagaki,et al.  Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. , 2008, Gastroenterology.

[50]  R. Hay,et al.  NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. , 2008, Journal of hepatology.

[51]  D. Schuppan,et al.  The hedgehog pathway regulates remodelling responses to biliary obstruction in rats , 2008, Gut.

[52]  Jianguo Lin,et al.  Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells , 2008, Laboratory Investigation.

[53]  H. Friess,et al.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.

[54]  J. Mann,et al.  Epigenetic regulation of hepatic stellate cell activation , 2008, Journal of gastroenterology and hepatology.

[55]  D. Brenner,et al.  High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate–activated protein kinase , 2008, Hepatology.

[56]  F. Marra,et al.  Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. , 2008, Molecular aspects of medicine.

[57]  M. Pekalski,et al.  Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.

[58]  R. Schwabe,et al.  Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[59]  Zhigang Tian,et al.  Liver: An organ with predominant innate immunity , 2007, Hepatology.

[60]  Ji Won Kim,et al.  Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. , 2008, Human pathology.

[61]  S. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[62]  Y. Kloog,et al.  The Effect of Ras Inhibition on the Proliferation, Apoptosis and Matrix Metalloproteases Activity in Rat Hepatic Stellate Cells , 2008, Digestive Diseases and Sciences.

[63]  M. Buck,et al.  A Ribosomal S-6 Kinase–Mediated Signal to C/EBP-β Is Critical for the Development of Liver Fibrosis , 2007, PloS one.

[64]  E. Olson,et al.  MEF2: a central regulator of diverse developmental programs , 2007, Development.

[65]  A. Dolganiuc,et al.  Innate immune response and hepatic inflammation. , 2007, Seminars in liver disease.

[66]  I. Leclercq,et al.  ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice , 2007, Hepatology.

[67]  D. A. Gomes,et al.  Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.

[68]  Yosuke Osawa,et al.  TLR4 enhances TGF-β signaling and hepatic fibrosis , 2007, Nature Medicine.

[69]  W. Jeong,et al.  Retinoic acid signaling sensitizes hepatic stellate cells to NK cell killing via upregulation of NK cell activating ligand RAE1. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[70]  R. Kalluri,et al.  Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.

[71]  A. Elsharkawy,et al.  Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis , 2007 .

[72]  Olivia T. Abar,et al.  A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C , 2007, Hepatology.

[73]  S. Terai,et al.  Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[74]  D. Stupack The biology of integrins. , 2007, Oncology.

[75]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[76]  Connie Wang,et al.  Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro* , 2007, Journal of Biological Chemistry.

[77]  T. Liang,et al.  Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma , 2007, Journal of Cancer Research and Clinical Oncology.

[78]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[79]  F. Marra,et al.  Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. , 2007, The American journal of pathology.

[80]  A. Gressner,et al.  Pro-fibrogenic potential of PDGF-D in liver fibrosis. , 2007, Journal of hepatology.

[81]  Y. Takei,et al.  Role of adipocytokines in hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.

[82]  J. Fallowfield,et al.  Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1 , 2007, The Journal of Immunology.

[83]  Shoana L. Sikorski,et al.  Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR , 2007, Science.

[84]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[85]  Didier Merlin,et al.  Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. , 2007, Cancer research.

[86]  J. Iredale,et al.  Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.

[87]  A. Mallat,et al.  Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases , 2007, Expert opinion on therapeutic targets.

[88]  Y. Inagaki,et al.  Emerging insights into Transforming growth factor β Smad signal in hepatic fibrogenesis , 2007, Gut.

[89]  A. Thorne,et al.  Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis , 2007, Cell Death and Differentiation.

[90]  R. Kalluri,et al.  Transcriptional regulation of epithelial-mesenchymal transition. , 2007, The Journal of clinical investigation.

[91]  H. Okano,et al.  Bone marrow–derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice , 2007, Hepatology.

[92]  W. Pu,et al.  Zeisberg, E.M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 , 2007 .

[93]  S. Friedman,et al.  The Role of Inflammation and Immunity in the Pathogenesis of Liver Fibrosis , 2007 .

[94]  F. Marra Leptin and liver tissue repair: do rodent models provide the answers? , 2007, Journal of hepatology.

[95]  Nils Cordes,et al.  Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.

[96]  J. Dranoff,et al.  Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[97]  W. Jeong,et al.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity , 2006, Hepatology.

[98]  C. Lechuga,et al.  PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[99]  S. Romagnani Regulation of the T cell response , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[100]  S. Sheikh,et al.  In Vitro and In Vivo Protection of Stellate Cells from Apoptosis by Leptin , 2006, Digestive Diseases and Sciences.

[101]  Christopher J. Parsons,et al.  Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. , 2006, Journal of hepatology.

[102]  M. Fraga,et al.  The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells. , 2006, Biochemical and biophysical research communications.

[103]  C. J. Marek,et al.  Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. , 2006, Gastroenterology.

[104]  S. Friedman,et al.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of hepatology.

[105]  C. Ledent,et al.  CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis , 2006, Nature Medicine.

[106]  Youhua Liu,et al.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. , 2006, The American journal of pathology.

[107]  S. Dooley,et al.  Id1 is a critical mediator in TGF‐β–induced transdifferentiation of rat hepatic stellate cells , 2006, Hepatology.

[108]  S. Forbes,et al.  The bone marrow functionally contributes to liver fibrosis. , 2006, Gastroenterology.

[109]  R. Wells,et al.  Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo , 2006, Journal of thrombosis and haemostasis : JTH.

[110]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[111]  A. P. Holt,et al.  Attenuated liver fibrosis in the absence of B cells , 2006, Hepatology.

[112]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[113]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[114]  S. Friedman,et al.  Reversal of hepatic fibrosis — Fact or fantasy? , 2006, Hepatology.

[115]  F. Marra,et al.  Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans , 2005, Gut.

[116]  Vinay Tergaonkar,et al.  NFκB pathway: A good signaling paradigm and therapeutic target , 2006 .

[117]  S. Dooley,et al.  TGF-β/Smad Signaling in the Injured Liver , 2006 .

[118]  S. Milani,et al.  Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells , 2005, Hepatology.

[119]  B. Luxon,et al.  Rat hepatic stellate cells become retinoid unresponsive during activation. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[120]  H. Tsukamoto Adipogenic phenotype of hepatic stellate cells. , 2005, Alcoholism, clinical and experimental research.

[121]  S. Shukla,et al.  Histone h3 modifications in rat hepatic stellate cells by ethanol. , 2005, Alcohol and alcoholism.

[122]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[123]  D. Brenner,et al.  Liver fibrogenesis: a new role for the renin-angiotensin system. , 2005, Antioxidants & redox signaling.

[124]  A. Morelli,et al.  A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis , 2005, Journal of Pharmacology and Experimental Therapeutics.

[125]  F. Anania,et al.  The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. , 2005, The American journal of pathology.

[126]  Sang -Geon Kim,et al.  meso-Dihydroguaiaretic Acid from Machilus thunbergii Down-Regulates TGF-β1 Gene Expression in Activated Hepatic Stellate Cells via Inhibition of AP-1 Activity , 2005, Planta medica.

[127]  Toshikazu Nakamura,et al.  Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. , 2005, The American journal of pathology.

[128]  B. Gao,et al.  Cytokines, STATs and liver disease. , 2005, Cellular & molecular immunology.

[129]  Liying Li,et al.  Antifibrogenic role of the cannabinoid receptor CB2 in the liver. , 2005, Gastroenterology.

[130]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[131]  D. Brenner,et al.  Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury , 2004, Gut.

[132]  B. Staels,et al.  The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.

[133]  Q. Tang,et al.  Involvement of C/EBP-α gene in in vitro activation of rat hepatic stellate cells , 2004 .

[134]  S. Friedman,et al.  Lhx2-/- mice develop liver fibrosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[135]  A. Morelli,et al.  The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.

[136]  S. Friedman,et al.  Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. , 2004, Gastroenterology.

[137]  F. Anania,et al.  Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[138]  J. Fallowfield,et al.  Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. , 2004, Gastroenterology.

[139]  M. Rugge,et al.  A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. , 2004, Gastroenterology.

[140]  R. Rippe,et al.  Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells* , 2004, Journal of Biological Chemistry.

[141]  K. Mak,et al.  Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells , 2004, Journal of Biological Chemistry.

[142]  William R. Sellers,et al.  PI3K/PTEN/Akt Pathway , 2004 .

[143]  C. Vinson,et al.  Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[145]  F. Tülübaş,et al.  Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation. , 2003, Hepato-gastroenterology.

[146]  R. Schwabe,et al.  NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.

[147]  W. Mckeehan,et al.  Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis. , 2003, The American journal of pathology.

[148]  H. Yoshiji,et al.  Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis , 2003, Gut.

[149]  G. Weinmaster,et al.  Basal Expression of IκBα Is Controlled by the Mammalian Transcriptional Repressor RBP-J (CBF1) and Its Activator Notch1* , 2003, Journal of Biological Chemistry.

[150]  R. Kalluri,et al.  BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.

[151]  R. Bataller,et al.  Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. , 2003, Gastroenterology.

[152]  Jianye Xu,et al.  Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[153]  Christian Jobin,et al.  Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells , 2003, Hepatology.

[154]  R. Groszmann,et al.  Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[155]  D. Rockey Vascular mediators in the injured liver , 2003, Hepatology.

[156]  William R Sellers,et al.  PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. , 2003, Cancer treatment and research.

[157]  F. Braet,et al.  Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. , 2002, Journal of hepatology.

[158]  F. Marra,et al.  Chemokines in liver inflammation and fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[159]  F. Lammert,et al.  Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.

[160]  M. Pinzani PDGF and signal transduction in hepatic stellate cells. , 2002, Frontiers in bioscience : a journal and virtual library.

[161]  D. Mann,et al.  Transcriptional regulation of hepatic stellate cell activation , 2002, Gut.

[162]  D. Rockey,et al.  Effects of endothelins on hepatic stellate cell synthesis of endothelin‐1 during hepatic wound healing , 2002, Journal of cellular physiology.

[163]  Hsin C. Lin,et al.  Discoidin Domain Receptor 2 Interacts with Src and Shc following Its Activation by Type I Collagen* , 2002, The Journal of Biological Chemistry.

[164]  Y. Takei,et al.  Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. , 2002, Gastroenterology.

[165]  F. Marra Leptin and liver fibrosis: a matter of fat. , 2002, Gastroenterology.

[166]  T. Thomas,et al.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension , 2002, Gut.

[167]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[168]  S. Friedman,et al.  Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.

[169]  A. Branch,et al.  Elevated Expression of Tyrosine Kinase DDR2 in Primary Biliary Cirrhosis , 2002, Autoimmunity.

[170]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[171]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[172]  M. Arthur,et al.  Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells , 2001, Gut.

[173]  J. Maher Interactions between Hepatic Stellate Cells and the Immune System , 2001, Seminars in liver disease.

[174]  D. Rockey Cellular pathophysiology of portal hypertension and prospects for management with gene therapy. , 2001, Clinics in liver disease.

[175]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[176]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[177]  J. Goergen,et al.  The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism , 2001, EMBO reports.

[178]  M. Serio,et al.  Signal Transduction by the Chemokine Receptor CXCR3 , 2001, The Journal of Biological Chemistry.

[179]  V. Desmet,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. , 2001, Hepatology.

[180]  H. Ikeda,et al.  Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. , 2000, Biochemical and biophysical research communications.

[181]  J. Iredale,et al.  Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. , 2000, Histology and histopathology.

[182]  A. Rivas-Estilla,et al.  Tumor necrosis factor α down‐regulates expression of the α1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPβ‐ and C/EBPδ‐dependent mechanism , 2000 .

[183]  S. Afford,et al.  Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. , 2000, The American journal of pathology.

[184]  A. Desmoulière,et al.  Deactivation of cultured human liver myofibroblasts by Trans‐resveratrol, a grapevine‐derived polyphenol , 2000, Hepatology.

[185]  A. Rivas-Estilla,et al.  Hydrogen peroxide: A link between acetaldehyde‐elicited α1(i) collagen gene up‐regulation and oxidative stress in mouse hepatic stellate cells , 2000, Hepatology.

[186]  M. Arthur,et al.  Persistent activation of nuclear factor‐κB in cultured rat hepatic stellate cells involves the induction of potentially novel rel‐like factors and prolonged changes in the expression of IκB family proteins , 1999, Hepatology.

[187]  A. Mallat,et al.  Biological Effects of C-type Natriuretic Peptide in Human Myofibroblastic Hepatic Stellate Cells* , 1999, The Journal of Biological Chemistry.

[188]  R. Bataller,et al.  Atrial natriuretic peptide antagonizes endothelin‐induced calcium increase and cell contraction in cultured human hepatic stellate cells , 1999, Hepatology.

[189]  H. Yee,et al.  Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance. , 1999, The American journal of physiology.

[190]  D. Schuppan,et al.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture , 1999, Hepatology.

[191]  D. Rockey,et al.  Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing* , 1999, The Journal of Biological Chemistry.

[192]  G. Ramadori,et al.  Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1 , 1999 .

[193]  S. Eichhorst,et al.  Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. , 1999, The American journal of pathology.

[194]  D. Rockey,et al.  Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[195]  Patrick P.L. Tam,et al.  SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.

[196]  H. Tsukamoto,et al.  Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. , 1997, The American journal of physiology.

[197]  T. Ueno,et al.  Intralobular innervation and lipocyte contractility in the liver. , 1997, Nutrition.

[198]  J. Iredale Tissue inhibitors of metalloproteinases in liver fibrosis. , 1997, The international journal of biochemistry & cell biology.

[199]  D. Beno,et al.  Suppression of Stellate Cell Type I Collagen Gene Expression Involves AP-2 Transmodulation of Nuclear Factor-1-dependent Gene Transcription* , 1996, The Journal of Biological Chemistry.

[200]  D. Brenner,et al.  Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells , 1996, Hepatology.

[201]  R. Kalluri,et al.  Possible mechanisms of renal fibrosis. , 1996, Contributions to nephrology.

[202]  H. Herbst,et al.  Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. , 1996, The American journal of pathology.

[203]  M. Suematsu,et al.  Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. , 1995, The Journal of clinical investigation.

[204]  M. Pinzani Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture , 1995 .

[205]  F. Anania,et al.  Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the α2(I) collagen promoter , 1995 .

[206]  Gressner Am Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995 .

[207]  A. Gressner Cytokines and cellular crosstalk involved in the activation of fat-storing cells. , 1995, Journal of hepatology.

[208]  S. Friedman,et al.  Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.

[209]  V. Carloni,et al.  Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. , 1994, Gastroenterology.

[210]  D. Rockey,et al.  Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[211]  N. Kawada,et al.  Eicosanoid-mediated contractility of hepatic stellate cells. , 1992, The Biochemical journal.

[212]  L. Gesualdo,et al.  Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. , 1992, The American journal of physiology.

[213]  M. Arthur,et al.  Wright's Liver and biliary disease : pathophysiology, diagnosis and management , 1992 .

[214]  Sims De Recent advances in pericyte biology--implications for health and disease. , 1991 .

[215]  D. Sims Recent advances in pericyte biology--implications for health and disease. , 1991, The Canadian journal of cardiology.

[216]  L. Gesualdo,et al.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. , 1989, The Journal of clinical investigation.

[217]  W. Thompson The fibrogenic response to tissue damage , 1980 .

[218]  V. Arroyo,et al.  Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis , 1980 .

[219]  V. Arroyo,et al.  Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. , 1980, Gastroenterology.

[220]  H. Popper,et al.  Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.